Rituximab combined to ACVBP (R-ACVBP) supported by pegfilgrastim as a new inductive treatment followed by high-dose consolidative autotransplantation (HDC) for poor risk diffuse large B-cell lymphoma (DLBCL) in first-line. Results of LNH 03-39B. A GELA study

被引：1

作者：

Belhadj, Karim ^{[1
]}

Jais, Jean-Philipp ^{[2
]}

Feugier, Pierre ^{[3
]}

Gisselbrecht, Christian ^{[4
]}

Recher, Christian ^{[5
]}

Casasnova, Olivier ^{[6
]}

Coiffier, Bertrand ^{[7
]}

Sebban, Catherine ^{[8
]}

Delmer, Alain ^{[9
]}

Morschhauser, Franck ^{[10
]}

Canioni, Daniele ^{[2
]}

Tilly, Herve ^{[11
]}

Haioun, Corinne ^{[1
]}

机构：

[1] Hop Henri Mondor, F-94010 Creteil, France

[2] Hop Necker Enfants Malad, Paris, France

[3] Brabois Hosp, Nancy, France

[4] St Louis Hosp, Paris, France

[5] Purpan Hosp, Toulouse, France

[6] Le Bocage Hosp, Dijon, France

[7] Hosp Ctr, Pierre Benite, France

[8] Ctr Leon Berard, F-69373 Lyon, France

[9] Hop Robert Debre, Reims, France

[10] Oscar Lambret Hosp, Lille, France

[11] Ctr Henri Becquerel, F-76038 Rouen, France

来源：

关键词：

D O I：

10.1182/blood.V110.11.3437.3437

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

3437

引用

页码：1007A / 1007A

页数：1